391 - 400 out of 468Page size: 10
  1. 2015

  2. TAAR1 Modulates Cortical Glutamate NMDA Receptor Function

    Espinoza, S., Lignani, G., Caffino, L., Maggi, S., Sukhanov, I., Leo, D., Mus, L., Emanuele, M., Ronzitti, G., Harmeier, A., Medrihan, L., Sotnikova, T. D., Chieregatti, E., Hoener, M. C., Benfenati, F., Tucci, V., Fumagalli, F. & Gainetdinov, R. R., 16 Aug 2015, In: Neuropsychopharmacology. 40, 9, p. 2217-2227 11 p.

    Research output: Contribution to journal › Article › peer-review

  3. Beyond Gene Inactivation: Evolution of Tools for Analysis of Serotonergic Circuitry

    Hainer, C., Mosienko, V., Koutsikou, S., Crook, J. J., Gloss, B., Kasparov, S., Lumb, B. M. & Alenina, N., 15 Jul 2015, In: ACS Chemical Neuroscience. 6, 7, p. 1116-1129 14 p.

    Research output: Contribution to journal › Article › peer-review

  4. Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1

    Espinoza, S., Ghisi, V., Emanuele, M., Leo, D., Sukhanov, I., Sotnikova, T. D., Chieregatti, E. & Gainetdinov, R. R., Jun 2015, In: Neuropharmacology. 93, p. 308-313 6 p.

    Research output: Contribution to journal › Article › peer-review

  5. Cell communication using intrinsically disordered proteins: What can syndecans say?

    Leonova, E. I. & Galzitskaya, O. V., 4 May 2015, In: Journal of Biomolecular Structure and Dynamics. 33, 5, p. 1037-1050 14 p.

    Research output: Contribution to journal › Article › peer-review

  6. Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits

    Masoud, S. T., Vecchio, L. M., Bergeron, Y., Hossain, M. M., Nguyen, L. T., Bermejo, M. K., Kile, B., Sotnikova, T. D., Siesser, W. B., Gainetdinov, R. R., Wightman, R. M., Caron, M. G., Richardson, J. R., Miller, G. W., Ramsey, A. J., Cyr, M. & Salahpour, A., 1 Feb 2015, In: Neurobiology of Disease. 74, p. 66-75 10 p.

    Research output: Contribution to journal › Article › peer-review

  7. Role of syndecans in lipid metabolism and human diseases

    Leonova, E. I. & Galzitskaya, O. V., 1 Jan 2015, In: Advances in Experimental Medicine and Biology. 855, p. 241-258 18 p.

    Research output: Contribution to journal › Article › peer-review

  8. The role of syndecan-2 in amyloid plaque formation

    Leonova, E. I. & Galzitskaya, O. V., 1 Jan 2015, In: Molecular Biology. 49, 1, p. 77-85 9 p.

    Research output: Contribution to journal › Review article › peer-review

  9. Beta-catenin in schizophrenia: Possibly deleterious novel mutation.

    Levchenko, A., Davtian, S., Freylichman, O., Zagrivnaya, M., Kostareva, A. & Malashichev, Y., 2015, In: Psychiatry Research. 228, 3, p. 843-848

    Research output: Contribution to journal › Article › peer-review

  10. De Novo Sequencing of Peptides from Top-Down Tandem Mass Spectra

    Vyatkina, K., Wu, S., Dekker, L. J. M., VanDuijn, M. M., Liu, X., Tolic, N., Dvorkin, M., Alexandrova, S., Luider, T. M., Pasa-Tolic, L. & Pevzner, P. A., 2015, In: Journal of Proteome Research. 14, 11, 13 p.

    Research output: Contribution to journal › Article

  11. In-vivo pharmacology of Trace-Amine Associated Receptor 1

    Lam, V. M., Espinoza, S., Gerasimov, A. S., Gainetdinov, R. R. & Salahpour, A., 2015, In: European Journal of Pharmacology. 763, Pt B, p. 136-42 7 p.

    Research output: Contribution to journal › Review article › peer-review

Previous 1...36 37 38 39 40 41 42 43 ...47 Next

ID: 54572